Impact Factor
3.38
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.74
797 total citations
h5-index
32
h5 depth signal
Cited share
64.0%
194 of 303
Total citations
797
Citation footprint
Metric signal
2.83
External metric anchor
Self-citation
5.4%
43 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United Kingdom
404
United States
250
Spain
159
Italy
147
France
114
Citing Fields of Research
HIV
1,134
Hepatitis
103
Oncology
44
Sexually Transmitted Diseases
33
Mycobacterial Diseases
27
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,076
Articles tracked across the journal lifetime
Indexed publication set
303
194 cited publications
Last 12 months
200
16.7 publications/month
Open access share
46.5%
93 OA publications in the last year
Leading citing country
United Kingdom
404 citing publications
Leading citing field
HIV
1,134 citing publications
Latest tracked publication
18 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Oct. 1999-
v1n1, Oct. 1999-
Active Coverage
Research Focus & Classification
Indexed Subjects
HIV
Issuing & Sponsoring Bodies
Contributor
British HIV Association
Contributor
European AIDS Clinical Society
Broad Categories
Acquired Immunodeficiency Syndrome
HIV
MeSH Descriptors
Acquired Immunodeficiency Syndrome
HIV Infections
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1111/hiv.70323
Open DOI
Pilot study of a ChatGPT ‐based educational and counselling tool in a specialist HIV and sexual health clinic
Objectives: Real‐world implementation of large language models such as ChatGPT to enhance patient education remains limited. We evaluated the feasibility, acceptability and attitudes towards a ChatGPT‐based counselling tool among patient...
02
DOI 10.1111/hiv.70333
Open DOI
Antiretroviral therapy intensification in people living with HIV on virological and clinical outcomes: A systematic review
Background: Antiretroviral therapy (ART) intensification involves increasing the dose or frequency of existing regimens or adding agents to standard therapy. This systematic review evaluated the impact of ART intensification on selected ...
03
DOI 10.1111/hiv.70325
Open DOI
Changes in cardiometabolic biomarkers 1 year after direct acting antiviral therapy for hepatitis C virus co‐infection among people with HIV
Objectives: Among people with HIV with hepatitis C virus (HCV) co‐infection, we examined differences in haemoglobin A1c (HbA1c), total cholesterol (TC), low‐density lipoprotein (LDL), high‐density lipoprotein (HDL) and atherosclerotic ca...
04
DOI 10.1111/hiv.70329
Open DOI
Information quality, understandability, actionability and readability of large language models for HIV health education: A cross‐platform evaluation
Objectives: Large language models (LLMs) are increasingly used to generate health education materials, but their suitability for patient‐facing human immunodeficiency virus (HIV) education remains insufficiently evaluated. We assessed th...
05
DOI 10.1111/hiv.70321
Open DOI
Breastfeeding and HIV in high‐income settings: Exploring women living with HIV and health care providers' perspectives in Belgium
Objectives: In high‐income countries, breastfeeding among women living with HIV remains controversial, despite evidence of a residual transmission risk below 1% on effective antiretroviral therapy (ART) with sustained viral suppression. ...
06
DOI 10.1111/hiv.70328
Open DOI
A retrospective cohort study of Ukrainian beneficiaries of temporary protection living with HIV attending an Irish tertiary care service
Objectives: To describe the demographic, clinical and healthcare utilization characteristics of Ukrainian beneficiaries of temporary protection living with HIV (UBOTPLWH) attending an Irish tertiary HIV service and to assess the impact o...
07
DOI 10.1111/hiv.70330
Open DOI
BHIVA Audit 2023: Prior engagement in HIV care among people living with HIV admitted to hospital
Objectives: To describe prior engagement in HIV care among people with HIV admitted to hospital in the United Kingdom and to examine clinical characteristics and causes of admission by engagement status. Methods: A national audit of adul...
08
DOI 10.1111/hiv.70320
Open DOI
Hepatitis D virus infection in persons with HIV and hepatitis B virus across Europe : A cross‐sectional analysis of the HDV‐Europe cohort
Introduction: Infection with hepatitis D virus (HDV) is known to accelerate the progression of liver disease and is associated with mortality in individuals with HIV and hepatitis B virus (HBV). However, little is known about current HDV...
09
DOI 10.1111/hiv.70317
Open DOI
A cross‐sectional analysis of cardiometabolic and lifestyle‐related profiles in men living with HIV in Japan using linked nationwide claims and health checkup data
Objectives: To compare objectively measured cardiometabolic health between people living with HIV (PLWH) and individuals without HIV using nationwide health checkup data linked to administrative claims, thereby partially mitigating surve...
10
DOI 10.1111/hiv.70322
Open DOI
Chronic alanine aminotransferase elevation in people with HIV : Time trends over 22 years and genetic predisposition
Introduction: Chronic elevation of alanine aminotransferase (cALT) is common in people with HIV. Published reports on cALT prevalence time trends have not been uniform. It is unknown whether genetic background is associated with cALT in ...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
Published on behalf of the British HIV Association and the European AIDS Clinical Society.
v.1, no. 1 (Oct. 1999)20020221 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper